Stephens & Co. Reiterates Overweight on Vericel, Maintains $65 Price Target
Benzinga Newsdesk 1 year ago
NewsPrice TargetReiterationAnalyst Ratings
Stephens & Co. analyst Mason Carrico reiterates Vericel (NASDAQ:VCEL) with a Overweight and maintains $65 price target.
Stephens & Co. analyst Mason Carrico reiterates Vericel (NASDAQ:VCEL) with a Overweight and maintains $65 price target.